FDA Approves First-Of-A-Kind Test for Cancer Gene Profiling - U.S. News & World Report

U.S. News & World Report

FDA Approves First-Of-A-Kind Test for Cancer Gene Profiling U.S. News & World Report U.S. officials have approved a first-of-a-kind test that looks for mutations in hundreds of cancer genes at once using a single tumor sample. Dec. 1, 2017, at 10:39 a.m.. FDA Approves First-Of-A-Kind Test for Cancer Gene Profiling. Share. ×. Share on ... How a New Genomic Test Could Change Cancer CareMedical Device and Diagnostics Industry FDA approves one-of-a-kind cancer gene testNew York Post Tumor Profiling Panel Undergoes Simultaneous FDA, CMS ReviewMedscape Xconomy -Futurism -Targeted Oncology -Healthcare Finance News all 49 news articles »

from Health - Google News http://ift.tt/2ACaP5R